BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17703938)

  • 1. Potent, nonsteroidal selective androgen receptor modulators (SARMs) based on 8H-[1,4]oxazino[2,3-f]quinolin-8-ones.
    Higuchi RI; Thompson AW; Chen JH; Caferro TR; Cummings ML; Deckhut CP; Adams ME; Tegley CM; Edwards JP; López FJ; Kallel EA; Karanewsky DS; Schrader WT; Marschke KB; Zhi L
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5442-6. PubMed ID: 17703938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones.
    Higuchi RI; Arienti KL; López FJ; Mani NS; Mais DE; Caferro TR; Long YO; Jones TK; Edwards JP; Zhi L; Schrader WT; Negro-Vilar A; Marschke KB
    J Med Chem; 2007 May; 50(10):2486-96. PubMed ID: 17439112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective androgen receptor modulators based on a series of 7H-[1,4]oxazino[3,2-g]quinolin-7-ones with improved in vivo activity.
    Long YO; Higuchi RI; Caferro TR; Lau TL; Wu M; Cummings ML; Martinborough EA; Marschke KB; Chang WY; López FJ; Karanewsky DS; Zhi L
    Bioorg Med Chem Lett; 2008 May; 18(9):2967-71. PubMed ID: 18400499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 6-aryl-1,4-dihydrobenzo[d]oxazine-2-thiones as potent, selective, and orally active nonsteroidal progesterone receptor agonists.
    Zhang P; Terefenko EA; Fensome A; Wrobel J; Winneker R; Zhang Z
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1313-6. PubMed ID: 12657271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of potent and tissue-selective androgen receptor modulators (SARMs): 2-(2,2,2)-Trifluoroethyl-benzimidazole scaffold.
    Ng RA; Lanter JC; Alford VC; Allan GF; Sbriscia T; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1784-7. PubMed ID: 17197181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 6-N,N-bis(2,2,2-trifluoroethyl)amino- 4-trifluoromethylquinolin-2(1H)-one as a novel selective androgen receptor modulator.
    van Oeveren A; Motamedi M; Mani NS; Marschke KB; López FJ; Schrader WT; Negro-Vilar A; Zhi L
    J Med Chem; 2006 Oct; 49(21):6143-6. PubMed ID: 17034117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsteroidal selective androgen receptor modulators enhance female sexual motivation.
    Jones A; Hwang DJ; Duke CB; He Y; Siddam A; Miller DD; Dalton JT
    J Pharmacol Exp Ther; 2010 Aug; 334(2):439-48. PubMed ID: 20444881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serendipitous discovery of novel imidazolopyrazole scaffold as selective androgen receptor modulators.
    Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2007 Jan; 17(2):439-43. PubMed ID: 17079140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one.
    Edwards JP; Higuchi RI; Winn DT; Pooley CL; Caferro TR; Hamann LG; Zhi L; Marschke KB; Goldman ME; Jones TK
    Bioorg Med Chem Lett; 1999 Apr; 9(7):1003-8. PubMed ID: 10230628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a novel class of nonsteroidal progesterone receptor agonists: effect of A-ring modification.
    Zhi L; Tegley CM; Marschke KB; Mais DE; Jones TK
    J Med Chem; 1999 Apr; 42(8):1466-72. PubMed ID: 10212133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel selective androgen receptor modulators: SAR studies on 6-bisalkylamino-2-quinolinones.
    van Oeveren A; Motamedi M; Martinborough E; Zhao S; Shen Y; West S; Chang W; Kallel A; Marschke KB; López FJ; Negro-Vilar A; Zhi L
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1527-31. PubMed ID: 17267219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile derivatives as potent and tissue selective androgen receptor modulators.
    Piatnitski Chekler EL; Unwalla R; Khan TA; Tangirala RS; Johnson M; St Andre M; Anderson JT; Kenney T; Chiparri S; McNally C; Kilbourne E; Thompson C; Nagpal S; Weber G; Schelling S; Owens J; Morris CA; Powell D; Verhoest PR; Gilbert AM
    J Med Chem; 2014 Mar; 57(6):2462-71. PubMed ID: 24527807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit.
    Mohler ML; Bohl CE; Jones A; Coss CC; Narayanan R; He Y; Hwang DJ; Dalton JT; Miller DD
    J Med Chem; 2009 Jun; 52(12):3597-617. PubMed ID: 19432422
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolines.
    Hamann LG; Higuchi RI; Zhi L; Edwards JP; Wang XN; Marschke KB; Kong JW; Farmer LJ; Jones TK
    J Med Chem; 1998 Feb; 41(4):623-39. PubMed ID: 9484511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate.
    Miner JN; Chang W; Chapman MS; Finn PD; Hong MH; López FJ; Marschke KB; Rosen J; Schrader W; Turner R; van Oeveren A; Viveros H; Zhi L; Negro-Vilar A
    Endocrinology; 2007 Jan; 148(1):363-73. PubMed ID: 17023534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of LGD-3303 [9-chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo-[3,2-f]quinolin-7(6H)-one], an orally available nonsteroidal-selective androgen receptor modulator.
    Vajda EG; López FJ; Rix P; Hill R; Chen Y; Lee KJ; O'Brien Z; Chang WY; Meglasson MD; Lee YH
    J Pharmacol Exp Ther; 2009 Feb; 328(2):663-70. PubMed ID: 19017848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators.
    Martinborough E; Shen Y; Oeveren Av; Long YO; Lau TL; Marschke KB; Chang WY; López FJ; Vajda EG; Rix PJ; Viveros OH; Negro-Vilar A; Zhi L
    J Med Chem; 2007 Oct; 50(21):5049-52. PubMed ID: 17887661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of potent and muscle selective androgen receptor modulators through scaffold modifications.
    Li JJ; Sutton JC; Nirschl A; Zou Y; Wang H; Sun C; Pi Z; Johnson R; Krystek SR; Seethala R; Golla R; Sleph PG; Beehler BC; Grover GJ; Fura A; Vyas VP; Li CY; Gougoutas JZ; Galella MA; Zahler R; Ostrowski J; Hamann LG
    J Med Chem; 2007 Jun; 50(13):3015-25. PubMed ID: 17552509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent nonsteroidal progesterone receptor agonists: synthesis and SAR study of 6-aryl benzoxazines.
    Zhang P; Terefenko EA; Fensome A; Zhang Z; Zhu Y; Cohen J; Winneker R; Wrobel J; Yardley J
    Bioorg Med Chem Lett; 2002 Mar; 12(5):787-90. PubMed ID: 11859003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g] quinolinone.
    Edwards JP; West SJ; Pooley CL; Marschke KB; Farmer LJ; Jones TK
    Bioorg Med Chem Lett; 1998 Apr; 8(7):745-50. PubMed ID: 9871534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.